CCI-779 Inhibits Rhabdomyosarcoma Xenograft Growth by an Antiangiogenic Mechanism Linked to the Targeting of mTOR/Hif-1α/VEGF Signaling

This publication has 48 references indexed in Scilit:

• Rapamycin Inhibits Ezrin-Mediated Metastatic Behavior in a Murine Model of Osteosarcoma
  Cancer Research, 2005
• Targeting HIF-1 for cancer therapy
  Nature Reviews Cancer, 2003
• Levels of PTEN protein modulate Akt phosphorylation on serine 473, but not on threonine 308, in IGF-II-overexpressing rhabdomyosarcomas cells
  Oncogene, 2003
• Rheb promotes cell growth as a component of the insulin/TOR signalling network
  Nature Cell Biology, 2003
• Rheb is an essential regulator of S6K in controlling cell growth in Drosophila
  Nature Cell Biology, 2003
• Role of angiogenesis in tumor growth and metastasis
  Seminars in Oncology, 2002
• Clinical translation of angiogenesis inhibitors
  Nature Reviews Cancer, 2002
• Pediatric genitourinary tumors
  Current Opinion in Oncology, 2002
• The rapamycin-sensitive signal transduction pathway as a target for cancer therapy
  Oncogene, 2000
• Rapamycin: A novel immunosuppressive macrolide
  Medicinal Research Reviews, 1994